Moreover, in a data set from the Tumor Cancer Genomic Atlas (TCGA), including 85 samples, sub-classified in classical (n = 17), mesenchymal (n = 27), neural (n = 17) and proneural (n = 24) GBM, we found that PATZ1 expression specifically correlates with the molecular subtype, being highest in proneural and lowest in mesenchymal subtype, with significant differences between each subtype (Figure 3B). The gene discussed is PATZ1; the disease is glioblastoma.